Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析

◆英語タイトル:Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH7427FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Novo Nordisk AS (NOVO B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novo Nordisk AS (Novo Nordisk), a subsidiary of Novo Holdings AS, is a healthcare company that discovers, develops and manufactures innovative biological medicines. It focuses on advancing drugs for the treatment of diabetes and other serious chronic conditions including hemophilia, human growth hormone (HGH) disorders and obesity. The company’s portfolio includes pre-filled delivery systems for insulin; glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. With subsidiaries in North America, Europe, Asia, Latin America, Africa, Middle East and Australia, the company markets its products in several countries worldwide. Novo Nordisk is headquartered in Bagsvaerd, Denmark.

Novo Nordisk AS Key Recent Developments

Feb 03,2021: Novo Nordisk”s net profit increased by 8% in 2020
Nov 09,2020: Novo Nordisk to acquire Emisphere Technologies for $1.8bn
Oct 30,2020: Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates in the first nine months of 2020
Oct 13,2020: Alexander Mann Solutions partners with Novo Nordisk to support its global healthcare recruitment requirements
Oct 08,2020: Novo Nordisk raises sales and operating profit outlook for 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Novo Nordisk AS – Key Facts
Novo Nordisk AS – Key Employees
Novo Nordisk AS – Key Employee Biographies
Novo Nordisk AS – Major Products and Services
Novo Nordisk AS – History
Novo Nordisk AS – Company Statement
Novo Nordisk AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Novo Nordisk AS – Business Description
Business Segment: Biopharmaceuticals
Overview
Performance
Business Segment: Diabetes and Obesity Care
Overview
Performance
Key Stats
Geographical Segment: International Operations
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Novo Nordisk AS – Corporate Strategy
Novo Nordisk AS – SWOT Analysis
SWOT Analysis – Overview
Novo Nordisk AS – Strengths
Novo Nordisk AS – Weaknesses
Novo Nordisk AS – Opportunities
Novo Nordisk AS – Threats
Novo Nordisk AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Novo Nordisk AS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novo Nordisk AS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novo Nordisk AS, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 03, 2021: Novo Nordisk”s net profit increased by 8% in 2020
Nov 09, 2020: Novo Nordisk to acquire Emisphere Technologies for $1.8bn
Oct 30, 2020: Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates in the first nine months of 2020
Oct 13, 2020: Alexander Mann Solutions partners with Novo Nordisk to support its global healthcare recruitment requirements
Oct 08, 2020: Novo Nordisk raises sales and operating profit outlook for 2020
Sep 24, 2020: World’s largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management
Sep 21, 2020: Novo Nordisk launches new 100% renewable power target for suppliers
Sep 10, 2020: ACC, Novo Nordisk partner to improve Cardiovascular Disease Management in patients with Type 2 Diabetes
Aug 18, 2020: Evotec and Novo Nordisk form strategic alliance to develop novel therapies for kidney diseases
Aug 14, 2020: Novo Nordisk invests DKK 850 million in production facilities in Kalundborg
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Novo Nordisk AS, Key Facts
Novo Nordisk AS, Key Employees
Novo Nordisk AS, Key Employee Biographies
Novo Nordisk AS, Major Products and Services
Novo Nordisk AS, History
Novo Nordisk AS, Subsidiaries
Novo Nordisk AS, Key Competitors
Novo Nordisk AS, Ratios based on current share price
Novo Nordisk AS, Annual Ratios
Novo Nordisk AS, Annual Ratios (Cont...1)
Novo Nordisk AS, Annual Ratios (Cont...2)
Novo Nordisk AS, Interim Ratios
Novo Nordisk AS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Novo Nordisk AS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Novo Nordisk AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nitto Denko Corp (6988):企業の財務・戦略的SWOT分析
    Nitto Denko Corp (6988) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Green Energy Options Ltd:企業の戦略的SWOT分析
    Green Energy Options Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ion Beam Applications SA (IBAB):企業の財務・戦略的SWOT分析
    Ion Beam Applications SA (IBAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dollar Tree Inc:戦略・SWOT・企業財務分析
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Viad Corp:企業の戦略・SWOT・財務情報
    Viad Corp - Strategy, SWOT and Corporate Finance Report Summary Viad Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MegaChips Corporation (6875):企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Janssen Pharmaceutica NV:企業のM&A・事業提携・投資動向
    Janssen Pharmaceutica NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceutica NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • SPI Energy Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Spi Energy Co Ltd (Spi Energy), formerly Solar Power Inc, is a photovoltaic (PV) solutions provider. The company offers development, financing, installation, operation and sale of utility-scale and residential solar power projects. It also operates online energy e-commerce and investment pla …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Vitasoy International Holdings Ltd (0345)
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aurora Energy Pty Ltd:企業の戦略・SWOT・財務分析
    Aurora Energy Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Aurora Energy Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆